Research Report for the year 2019

Scientific publications

Journal Articles:
  • Fecker J, Schumacher M, Ohneberg K, Wolkewitz M: Correction of Survival Bias in a Study About Increased Mortality of Heads of Government. Am Stat, 2019 (online): 1537-2731. : https://doi.org/10.1080/00031305.2019.1638831
  • Gomila A, Carratalà J, Eliakim-Raz N, Shaw E, Tebé C, Wolkewitz M, Wiegand I, Grier S, Vank C, Cuperus N, Van den Heuvel L, Vuong C, MacGowan A, Leibovici L, Addy I, Pujol M, & on behalf of RESCUING Study Group, Study Sites: Clinical outcomes of hospitalised patients with catheter-associated urinary tract infection in countries with a high rate of multidrug-resistance: the COMBACTE-MAGNET RESCUING study. Antimicrob Resist in, 2019; 8 (online): 198. : https://doi.org/10.1186/s13756-019-0656-6
  • Hagel S, Ludewig K, Pletz MW, Frosinski J, Moeser A, Wolkewitz M, Gastmeier P, Harbarth S, Brunkhorst FM, Kesselmeier M, Scherag A: Effectiveness of a hospital-wide infection control programme on the incidence of healthcare-associated infections and associated severe sepsis and septic shock: a prospective interventional study. Clin Microbiol Infec, 2019; 25: 462-468. : https://doi.org/10.1016/j.cmi.2018.07.010
  • Heister T, Wolkewitz M, Hehn P, Wolff J, Dettenkofer M, Grundmann H, Kaier K: Costs of hospital-acquired Clostridium difficile infections: an analysis on the effect of time-dependent exposures using routine and surveillance data. Cost Effectiveness and Resource Allocation, 2019; 17: 16. : https://doi.org/10.1186/s12962-019-0184-5
  • Kaier K, Heister T, Götting T, Wolkewitz M, Mutters NT: Measuring the in-hospital costs of Pseudomonas aeruginosa pneumonia: methodology and results from a German teaching hospital. Bmc Infect Dis, 2019; 19 (online): 1028. : https://doi.org/10.1186/s12879-019-4660-5
  • Kaier K, Heister T, Motschall E, Hehn P, Bluhmki T, Wolkewitz M: Impact of mechanical ventilation on the daily costs of ICU care: a systematic review and meta regression. Epidemiol Infect, 2019; 147 (online): e314. : https://doi.org/10.1017/S0950268819001900
  • Kaier K, Wolkewitz M, Hehn P, Mutters NT, Heister T: The impact of hospital-acquired infections on the patient-level reimbursement-cost relationship in a DRG-based hospital payment system. Int J Health Econ Ma, 2019. : https://doi.org/10.1007/s10754-019-09267-w (in Druck)
  • Rieg S, von Cube M, Kaasch A, Bonaventura B, Bothe W, Wolkewitz M, Peyerl-Hoffmann G, Deppe AC, Wahlers T, Beyersdorf F, Seifert H, Kern WV: Investigating the impact of early valve surgery on survival in Staphylococcus aureus infective endocarditis using a marginal structural model approach - results of a large prospectively evaluated cohort. Clin Infect Dis, 2019; 69: 487-494. : https://doi.org/10.1093/cid/ciy908
  • Tacconelli E, Sifakis F, Harbarth S, Schrijver R, van Mourik M, Voss A, Sharland M, Rajendran NB, Rodriguez-Bano, Wolkewitz M, J Group Author(s): EPI-Net COMBACTE-MAGNET. Surveillance for control of antimicrobial resistance. Lancet Infect Dis, 2019; 18 (online): E99-E106. : http://dx.doi.org/10.1016/S1473-3099(17)30485-1
  • von Cube M, Schumacher M, Bailly S, Timsit JF, Lepape A, Savey A, Machut A, Wolkewitz M: The population-attributable fraction for time-dependent exposures and competing risks-A discussion on estimands. Stat Med, 2019; 38: 3880-3895. : https://doi.org/10.1002/sim.8208
  • von Cube M, Schumacher M, Putter H, Timsit JF, van de Velde C, Wolkewitz M: The population-attributable fraction for time-dependent exposures using dynamic prediction and landmarking. Biometrical J, 2019. : https://doi.org/10.1002/bimj.201800252 (in Druck)
  • von Cube M, Schumacher M, Wolkewitz M: Causal inference with multistate models—estimands and estimators of the population attributable fraction. J R Stat Soc A Stat, 2019. : https://doi.org/10.1111/rssa.12486 (in Druck)
  • Wolkewitz M, Palomar-Martinez M, Alvarez-Lerma F, Olaechea-Astigarraga P, Schumacher M: Analyzing the impact of duration of ventilation, hospitalization, and ventilation episodes on the risk of pneumonia. Infect Cont Hosp Ep, 2019; 40: 301-306. : https://doi.org/10.1017/ice.2018.360
  • Wolkewitz M, Schumacher M, Rücker G, Harbarth S, Beyersmann J: Estimands to quantify prolonged hospital stay associated with nosocomial infections. Bmc Med Res Methodol, 2019; 19 (online): 111. : https://doi.org/10.1186/s12874-019-0752-6
Short Communications:
  • Kaier K, Mutters NT, Wolkewitz M: Measuring the financial burden of resistance: What should be compared? Clin Infect Dis, 2019; 69: 1082. : https://doi.org/10.1093/cid/ciz096
  • Ohneberg K, Wolkewitz M, Schumacher M: RE: "Risk Set Matching to Assess the Impact of Hospital-Acquired Bloodstream Infections." Am J Epidemiol, 2019; 188: 1192-1193. : https://doi.org/10.1093/aje/kwz035
  • von Cube MK, Schumacher M, Wolkewitz M: Follow-on rifaximin for the prevention of recurrence following standard treatment of infection with Clostridium difficile: a competing risks analysis provides a full picture of possible treatment effects. Gut, 2019. : https://doi.org/10.1136/gutjnl-2018-317839 (in Druck)